Development of a yeast bio-assay to screen anti-mitochondrial drugs

Current Drug Discovery Technologies

Volumn 6, Issue 3, 2009, Pages 186-191

  Kock, Johan L F ^a   Swart, Chantel W ^a   Ncango, Desmond M ^a   Kock Jr , Johan L F ^b   Munnik, Ingrid A ^a   Maartens, Marleen M J ^a   Pohl, Carolina H ^a   Van Wyk, Pieter W J ^a  

^a UNIVERSITY OF THE FREE STATE   (South Africa)

^b UNIVERSITY OF PRETORIA   (South Africa)

Author keywords

Anti inflammatory; Anti mitochondrion; Anticancer; Antifungal; Bio assay; Yeast

Indexed keywords

ACETYLSALICYLIC ACID; ALCOHOL; AMPHOTERICIN B; ANTIINFLAMMATORY AGENT; ANTINEOPLASTIC AGENT; BENZOIC ACID; ETHIDIUM BROMIDE; FLUCYTOSINE; FORMIC ACID; HYDROCHLORIC ACID; IBUPROFEN; INDOMETACIN; LONIDAMINE; OXYGEN; RIBOFLAVIN; SALICYLIC ACID; SODIUM HYDROXIDE;

ANTIFUNGAL ACTIVITY; ARTICLE; ASCOSPORE; BIOASSAY; CONTROLLED STUDY; DRUG SCREENING; FUNGUS HYPHAE; MAMMAL CELL; MITOCHONDRIAL MEMBRANE; NONHUMAN; PRIORITY JOURNAL; SEXUAL DEVELOPMENT; YEAST;

ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; ANTIFUNGAL AGENTS; ANTINEOPLASTIC AGENTS; BIOLOGICAL ASSAY; DRUG EVALUATION, PRECLINICAL; EREMOTHECIUM; INDAZOLES; MITOCHONDRIA; OXYGEN; OXYLIPINS;

EID: 69249132172     PISSN: 15701638     EISSN: None     Source Type: Journal    
DOI: 10.2174/157016309789054960     Document Type: Article

References (28)

1. Kock JLF, Sebolai OM, Pohl CH, van Wyk PWJ, Lodolo EJ. Oxylipin studies expose aspirin as antifungal. FEMS Yeast Res 2007; 7: 1207-1217
2. Sreenivasan PK, Gaffar A. Antibacterials as anti-inflammatory agents: Dual action agents for oral health. Antonie van Leeuwenhoek 2008; 93: 227-239 (Pubitemid 351167818)
3. Wickerham LJ. Taxonomy of Yeasts. Washington, DC. US Department of Agriculture 1951; Technical Bulletin No. 1029.
4. th Edn; Kurtzman CP, Fell JW, Eds.; Elsevier Science B.V: Amsterdam 1998; pp. 80-89
5. Sagone AL, Husney RM. Oxidation of salicylates by stimulated granulocytes: evidence that these drugs act as free radical scavengers in biological systems. J Immunology 1987; 138: 2177-2183
6. Mackowiak PA. Brief history of antipyretic therapy. Clin Infect Dis 2000; 31: S154-6.
7. Pina-Vaz C, Sansonetty F, Rodrigues AG, Matrinez-de-Oliviera J, Fonseca AF, Mardh P. Antifungal activity of ibuprofen alone and in combination with fluconazole against Candida species. J Med Microbiol 2000; 49: 831-840 (Pubitemid 30666636)
8. Costantini P, Jacotot E, Decaudin D, Kroemer G. Mitochondrion as a novel target of anticancer chemotherapy. J Nat Cancer Inst 2000; 92: 1042-1053 (Pubitemid 30616479)
9. Kaplan L, Demain AL. In Recent trends in yeast research - spectrum monograph series; Ahearn DG, Ed.; Atlanta: Georgia State University 1970; pp. 137-159
10. Ncango MD. Oxylipins in the yeast genus Ascoidea. M.Sc. Thesis, Department of Microbial, Biochemical and Food Biotechnology, University of the Free State, Bloemfontein, South Africa 2007.
11. Ncango MD, Swart CW, Goldblatt ME, et al. Oxylipin and mitochondrion probes to track yeast sexual cells. Can J Microbiol 2008; 54: 450-455
12. Johnson LV, Walsh ML, Chen LB. Localization of mitochondria in living cells with rhodamine 123. Proc Natl Acad Sci USA 1980; 77: 990-994
13. Armstrong JS. Mitochondria: a target for cancer therapy. Br J Pharmacol 2006; 147: 239-248
14. Bachmann SP, VandeWalle K, Ramage G, et al. In vitro activity of capsofungin against Candida albicans biofilms. Antimicrob Agents Chemother 2002; 46: 3591-3596
15. Strauss CJ, van Wyk PWJ, Lodolo EJ, et al. Mitochondrial associated yeast flocculation - the effect of acetylsalicylic acid. J Inst Brew 2007; 113: 42-47 (Pubitemid 46942078)
16. Moss BJ, Kim Y, Nandakumar MP, Marten MR. Quantifying metabolic activity of filamentous fungi using a colorimetric XTT assay. Biotechnol Prog 2008; 24: 780-783 (Pubitemid 351832737)
17. De Hoog GS, Kurtzman CP, Phaff HJ, Miller MW. In The Yeast, A Taxonomic Study, 4th Ed; Kurtzman CP, Fell JW, Eds.; Elsevier Science B.V: Amsterdam 1998; pp. 201-208
18. Brun S, Dalle F, Saulnier P, et al. Biological consequences of petite mutations in Candida glabrata. J Antimicrob Chemother 2005; 56: 307-314
19. Al-Nasser IA. Ibuprofen-induced liver mitochondrial permeability transition. Toxicol Lett 2000; 111: 213-218 (Pubitemid 30001875)
20. Somasundaram S, Sigthorsson G, Simpson RJ, et al. Uncoupling of intestinal mitochondrial oxidative phosphorylation and inhibition of cyclooxygenase are required for the development of NSAID-enteropathy in the rat. Aliment Pharmacol Ther 2000; 14: 639-650 (Pubitemid 30240758)
21. Norman C, Howell KA, Millar AH, Whelan JM, Day DA. Salicylic acid is an uncoupler and inhibitor of mitochondrial electron transport. Plant Physiol 2004; 134: 492-501. (Pubitemid 38178720)
22. 2+ levels in non steroidal anti-inflammatory drug-induced apoptosis. J Biol Chem 2005; 280: 31059-31067
23. Ludovico P, Sansonetty F, Corte-Real M. Assessment of mitochondrial membrane potential in yeast cell populations by flow cytometry. Microbiology 2001; 147: 3335-3343 (Pubitemid 33150339)
24. Chen LB. Mitochondrion membrane potential in living cells. Ann Rev Cell Biol 1988; 4: 155-181
25. Kock JLF, Strauss CJ, Pretorius EE, et al. Revealing yeast spore movement in confined space. S Afr J Sci 2004; 100(2): 237-240
26. Antachopoulus C, Meletiadis J, Roilides E, Sein T, Walsh TJ. Rapid susceptibility testing of medically important zygomycetes by XTT assay. J Clin Microbiol 2006; 44: 553-560 (Pubitemid 43222251)
27. Tellier R, Krajden M, Grigoriew GA, Campbell I. Innovative endpoint determination system for antifungal susceptibility in yeasts. Antimicrob Agents Chemother 1992; 36: 1619-1625
28. Gray MW, Burger G, Lang BF. The origin and early evolution of mitochondria. Genom Biol 2001; 2: 1018.1-8.5.